SHILPAMED Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > shilpamed

Technical Analysis

Technical Strength: 3.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 44.5. According to RSI analysis, shilpamed is weak. 3.0 SHILPAMED RSI Chart
MACD (?) MACD: -5.33 and Signal Line: -3.91. According to MACD analysis, shilpamed is technically weak. 2.0 SHILPAMED MACD Chart
Simple Moving Average (?) According to simple moving average analysis, shilpamed is in a downtrend. Resistance level is at 637. 1.0 SHILPAMED Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, shilpamed is in a downtrend. Resistance level is at 634. 1.0 SHILPAMED Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.282. 5.0 SHILPAMED Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% level. Support is at 609.8134 Resistance levels are 627.95 and 646.0866. 6.5 SHILPAMED Fibonacci Retracement Chart
Average True Range (?) ATR: 20.1 NA SHILPAMED Average True Range Chart
Average Directional Index (?) ADX is 14 which means SHILPAMED is in a trading range and there is no trend. NA SHILPAMED Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
December 14, 2017
Open Price 628.5
High Price 634.75
Low Price 621.4
Close Price 623.5
Absolute Change -5.45
Percentage Change -0.867%
Weekly Change 0.833%
Monthly Change 0.972%
Yearly Change -5.34%
52-week high 786.9
52-week low 535.1
Corporate Actions
ExDate Purpose
September 21, 2017 ANNUAL GENERAL MEETING
March 21, 2017 INT DIV RE 0.60 PER SHARE
March 28, 2016 INT DIV-RE 0.60 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.763
Confidence in Beta8.24%
Market Capital Rs. 2403.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 14.38
TTM Price-to-Earnings (P/E) Ratio 43.4
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 14 December 2017: Deliverable Quantity:6.86e+03 NA SHILPAMED Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 14 December 2017: Daily Volatility:0.3783 NA SHILPAMED Annualized Daily Volatility (Spot Price) Chart

Announcements

December 06, 2017 SUpdatesShilpa Medicare Limited has informed the Exchange regarding 'we hereby intimate you that SHILPA MEDICARE LIMITED has received 483 Observations from the United States Food & Drug Administration (USFDA) in relation to SEZ Formulation Facilities situated at Jadcherla, Telangana (near Hyderabad) as under;
November 17, 2017 SUpdatesShilpa Medicare Limited has informed the Exchange regarding 'Newspaper Publication'.We are enclosing herewith paper cuttings of the notice published in newspaper viz. Business Standard and Suddimoola (Kannada Daily) on 15th November 2017 with regard to publication of Financial Results for the Second Quarter ended 30th September, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 06, 2017 November 13, 2017 iResultsinter alia to consider the Un-audited Financial Results for the Second Quarter ended September 30, 2017.
August 01, 2017 August 10, 2017 iResultsinter alia to consider the Un-audited Financial Results for the First Quarter ended 30th June, 2017 in compliance of Regulation 33 of the SEBI (LODR) Regulations, 2015.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 605 Rs. 613.2 Rs. 618.4 Rs. 626.6 Rs. 631.7 Rs. 639.9 Rs. 645.1